Intratympanal administration of lidocaine in the management of Ménière's Disease.

ola Kala shared this article with you from Inoreader Intratympanal administration of lidocaine in the management of Ménière's Disease. Μέσω pubmed: "acta otolaryngol"[j... Related Articles Intratympanal administration of lidocaine in the management of Ménière's Disease. Acta Otolaryngol. 2020 Nov 16;:1-7 Authors: Bertlich M, Ihler F, Spiegel JL, Canis M, Weiss BG Abstract BACKGROUND: Ménière's Disease (MD) is a chronic condition where patients suffer recurrent vertigo attacks. Evidence for treatment concepts are to this date low. AIMS/OBJECTIVE: To evaluate the therapeutic effect of intratympanic lidocaine injections to reduce the number of attacks. METHODS: Twenty patients diagnosed with definitive MD that were treated with 34 intratympanic lidocaine injections were included. Main outcome measures were the number of vertigo attacks in the previous four weeks, the attack free period and the subjective improvement of the condition. RESULTS: Mean follow up after first lidocaine injection was 25.3 months (±22.2; range 1.9-79.7). Patients expressed subjective improvement in overall situation, vertigo, and aural fullness. The number of vertigo attacks before each assessment decreased from 7.1 (±5.9; range 2-20) per months at baseline to 1.9 (±3.8; range 0-15). 25% of the patients suffered no further attacks, the other patients had an average attack free period of 7.8 months (±15.4; range 0.2-58.4). Hearing thresholds remained unaffected. Repetitive injections proved effective. CONCLUSION AND SIGNIFICANCE: Intratympanic lidocaine is an effective nonsurgical and non-ablative therapy for MD. When patients experience an increase of attacks repetitive injections promise improvement. PMID: 33190578 [PubMed - as supplied by publisher] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.